Products Description of Noopept CAS#157115-85-0
N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester, marketed under the trade name NOOPEPT, is a compound used in the treatment of obesity, alcohol dependence, degenerative conditions, and toxic injuries.
Key Physical & Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C₁₇H₂₂N₂O₄ |
| Appearance | White to off-white crystalline solid |
| Solubility | Soluble in organic solvents; limited in water |
| Structure | Dipeptide (Pro-Gly) with N-phenylacetyl and ethyl ester |
| Typical Purity | ≥ 99% |
| Form | Powder / crystalline |
Applications
Laboratory Research:
Widely used as a research-grade compound in cognitive and neuropharmacology studies to explore memory, learning, and neuroprotective mechanisms across in-vitro and animal models. Consistent purity supports reproducible experiments.
Specialty Synthesis:
Serves as an intermediate in peptide and fine-chemical synthesis, where its phenylacetyl-prolylglycine backbone can be modified to build novel analogues and support structure-activity relationship (SAR) studies.
Reference Standard:
Supplied as a high-purity (≥ 99%) analytical standard for calibrating HPLC/LC-MS systems, enabling accurate identification, quantification, and impurity profiling of related compounds.
